Global Glycated Haemoglobin Testing Market Report and Forecast 2024-2032

Global Glycated Haemoglobin Testing Market Outlook

The global glycated haemoglobin testing market witnessed a healthy growth in the historical period of 2018-2023 aided by rising prevalence of diabetes. The market is expected to grow at a CAGR of 9% during the forecast period of 2024-2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Expected to be a Key Contributor to Global Glycated Haemoglobin Testing Market

North America seems to have a major share in the glycated haemoglobin testing market owing to increasing incidence of diabetes in regions like the United States and Canada. Hectic lifestyles and mindless eating habits in the region have led to a surge in the demand for glucose testing, thereby driving the global glycated haemoglobin testing market. Rising awareness among people about diseases like diabetes is driving them to opt for treatments. Moreover, the increasing adoption of point-of-care testing facilities, especially in developed economies has contributed significantly to the global glycated haemoglobin testing market growth.

Glycated Haemoglobin Testing: Market Segmentation

Glycated haemoglobin is measured to identify the three-month average plasma glucose concentration. Being a reliable index for long-term measure of glycemic level, the test is now considered as a cornerstone for diabetes management. The test is limited to a three-month average, owing to the four-month lifespan if red blood cells.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By product type, the market can be segmented into:

• Laboratory HbA1c Testing Products
• Point of Care (POC) HbA1c Testing Products

Based on technology, the market can be bifurcated into:

• Chromatography
• Immunoassay
• Others

Based on end use, the market can be divided into:

• Hospitals
• Diagnostic Centres
• Physical Examination Institution
• Research Institution
• Others

The regional markets for the product include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Prevalence of Diabetes is Driving the Market Growth

Rising prevalence of diabetes across the globe is driving the global glycated haemoglobin testing market growth. The market is expected to register significant growth in the market since there’s only one therapy given to the patients. Moreover, increasing awareness in people regarding diabetes and the rising demand for new treatments is driving the market forward. In addition to this, glycated haemoglobin testing has observed growth owing to the availability of point-of-care HbA1c testing devices. The test provides significant advantages over traditional blood glucose monitoring assays, including high sample stability, low day-to-day variation and no prior fasting requirement. This, in turn, is expected to propel the market growth.

Key Industry Players in the Global Glycated Haemoglobin Testing Market

The report gives a detailed analysis of the following key players in the global glycated haemoglobin testing market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Abbott Laboratories
• Siemens AG
• Danaher Corp.
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Randox Laboratories Ltd.
• Arkray, Inc.
• Others

The comprehensive EMR report provides an in-depth assessment of the industry based on Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report